Celldex Therapeutics-Does Celldex (CLDX) Have the Potential to Rally 71.82% as Wall Street Analysts Expect?

Celldex Therapeutics (CLDX) closed the last trading session at $40.49, gaining 5.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 69.57 indicates a 71.8% upside potential. The mean estimate comprises seven short-term price targets with a standard deviation of $20.30. While the lowest estimate of$ 27 indicates a 33.3% decline from the current price level, the most optimistic anal ...